These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 15218241

  • 1. Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma.
    Stallings RL, Carty P, McArdle L, Mullarkey M, McDermott M, O'Meara A, Ryan E, Catchpoole D, Breatnach F.
    Cytogenet Genome Res; 2004; 106(1):49-54. PubMed ID: 15218241
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.
    Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Lampert F, Boecker W, Dockhorn-Dworniczak B.
    Med Pediatr Oncol; 2001 Jan; 36(1):11-3. PubMed ID: 11464859
    [Abstract] [Full Text] [Related]

  • 4. Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.
    Spitz R, Hero B, Ernestus K, Berthold F.
    Clin Cancer Res; 2003 Oct 15; 9(13):4835-40. PubMed ID: 14581355
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Alternative pathways of MYCN gene copy number increase in primary neuroblastoma tumors.
    Valent A, Guillaud-Bataille M, Farra C, Lozach F, Spengler B, Terrier-Lacombe MJ, Valteau-Couanet D, Danglot G, Lenoir GM, Brison O, Bénard J, Bernheim A.
    Cancer Genet Cytogenet; 2004 Aug 15; 153(1):10-5. PubMed ID: 15325088
    [Abstract] [Full Text] [Related]

  • 7. Distinct cytogenetic pathways of advanced-stage neuroblastoma tumors, detected by spectral karyotyping.
    Stark B, Jeison M, Bar-Am I, Glaser-Gabay L, Mardoukh J, Luria D, Feinmesser M, Goshen Y, Stein J, Abramov A, Zaizov R, Yaniv I.
    Genes Chromosomes Cancer; 2002 Jul 15; 34(3):313-24. PubMed ID: 12007192
    [Abstract] [Full Text] [Related]

  • 8. Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma?
    Stallings RL, Howard J, Dunlop A, Mullarkey M, McDermott M, Breatnach F, O'Meara A.
    Cancer Genet Cytogenet; 2003 Jan 15; 140(2):133-7. PubMed ID: 12645651
    [Abstract] [Full Text] [Related]

  • 9. Comparing histopathological classification with MYCN, 1p36 and 17q status detected by fluorescence in situ hybridisation from 14 untreated primary neuroblastomas in Singapore.
    Yong MH, Hwang WS, Knight LA, Fung W, Chan MY, Seow WT, Chui CH.
    Singapore Med J; 2009 Nov 15; 50(11):1090-4. PubMed ID: 19960166
    [Abstract] [Full Text] [Related]

  • 10. MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification.
    Spitz R, Hero B, Skowron M, Ernestus K, Berthold F.
    Eur J Cancer; 2004 Dec 15; 40(18):2753-9. PubMed ID: 15571958
    [Abstract] [Full Text] [Related]

  • 11. Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization.
    Scaruffi P, Coco S, Cifuentes F, Albino D, Nair M, Defferrari R, Mazzocco K, Tonini GP.
    Cancer Genet Cytogenet; 2007 Aug 15; 177(1):20-9. PubMed ID: 17693187
    [Abstract] [Full Text] [Related]

  • 12. FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.
    Spitz R, Hero B, Ernestus K, Berthold F.
    Med Pediatr Oncol; 2003 Jul 15; 41(1):30-5. PubMed ID: 12764740
    [Abstract] [Full Text] [Related]

  • 13. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.
    Mosse YP, Diskin SJ, Wasserman N, Rinaldi K, Attiyeh EF, Cole K, Jagannathan J, Bhambhani K, Winter C, Maris JM.
    Genes Chromosomes Cancer; 2007 Oct 15; 46(10):936-49. PubMed ID: 17647283
    [Abstract] [Full Text] [Related]

  • 14. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization.
    Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC, Feuerstein BG.
    Am J Pathol; 1997 Jan 15; 150(1):81-9. PubMed ID: 9006325
    [Abstract] [Full Text] [Related]

  • 15. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
    Bown N, Lastowska M, Cotterill S, O'Neill S, Ellershaw C, Roberts P, Lewis I, Pearson AD, U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
    Med Pediatr Oncol; 2001 Jan 15; 36(1):14-9. PubMed ID: 11464868
    [Abstract] [Full Text] [Related]

  • 16. MYCN gain and MYCN amplification in a stage 4S neuroblastoma.
    Noguera R, Cañete A, Pellín A, Ruiz A, Tasso M, Navarro S, Castel V, Llombart-Bosch A.
    Cancer Genet Cytogenet; 2003 Jan 15; 140(2):157-61. PubMed ID: 12645655
    [Abstract] [Full Text] [Related]

  • 17. 2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics.
    Jeison M, Ash S, Halevy-Berko G, Mardoukh J, Luria D, Avigad S, Feinberg-Gorenshtein G, Goshen Y, Hertzel G, Kapelushnik J, Ben Barak A, Attias D, Steinberg R, Stein J, Stark B, Yaniv I.
    Am J Pathol; 2010 Jun 15; 176(6):2616-25. PubMed ID: 20395439
    [Abstract] [Full Text] [Related]

  • 18. Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?
    Vandesompele J, Speleman F, Van Roy N, Laureys G, Brinskchmidt C, Christiansen H, Lampert F, Lastowska M, Bown N, Pearson A, Nicholson JC, Ross F, Combaret V, Delattre O, Feuerstein BG, Plantaz D.
    Med Pediatr Oncol; 2001 Jan 15; 36(1):5-10. PubMed ID: 11464905
    [Abstract] [Full Text] [Related]

  • 19. Molecular cytogenetic analysis of recurrent unbalanced t(11;17) in neuroblastoma.
    Stallings RL, Carty P, McArdle L, Mullarkey M, McDermott M, Breatnach F, O'Meara A.
    Cancer Genet Cytogenet; 2004 Oct 01; 154(1):44-51. PubMed ID: 15381371
    [Abstract] [Full Text] [Related]

  • 20. Genes proximal and distal to MYCN are highly expressed in human neuroblastoma as visualized by comparative expressed sequence hybridization.
    Stock C, Bozsaky E, Watzinger F, Poetschger U, Orel L, Lion T, Kowalska A, Ambros PF.
    Am J Pathol; 2008 Jan 01; 172(1):203-14. PubMed ID: 18165268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.